EHSI Elite Health Systems (EHSI) Insider Trading, Ownership & Congress Trades
Healthcare Services · Services-specialty outpatient facilities, nec · CIK 0001089815
C-suite buying · 1
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about EHSI
Insiders, 180 days
+$52.6K net bought
1 buyer
Elite Health Systems insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Elite Health Systems Inc. insiders bought a net $52.6K of stock across 7 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 6 earlier Form 4 trades (code P or S) here by this insider (6 buys), the last on Jun 1, 2026.
- -13.9% median (-12.8% mean) 90-day return after 6 previous buys.
- The trade is 1.2% of the 3,624,484 shares held after it.
- No other insider bought within 30 days.
Insider activity: CEO jeereddi Prasad Anjaneya bought about $40.0K of EHSI on Jul 2, 2026.Context
- 5 earlier Form 4 trades (code P or S) here by this insider (5 buys), the last on May 15, 2026.
- -11.9% median (-11.9% mean) 90-day return after 5 previous buys.
- The trade is 2.5% of the 239,423 shares held after it.
- No other insider bought within 30 days.
Insider activity: CEO jeereddi Prasad Anjaneya bought about $6.3K of EHSI on Jun 1, 2026.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 buys), the last on Apr 29, 2026.
- -10.0% median (-10.8% mean) 90-day return after 4 previous buys.
- The trade is 2.6% of the 233,423 shares held after it.
- No other insider bought within 30 days.
Insider activity: CEO jeereddi Prasad Anjaneya bought about $6.3K of EHSI on May 15, 2026.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Jan 8, 2026.
- -8.2% median (-8.9% mean) 90-day return after 3 previous buys.
- The trade is 0.8% of the 227,423 shares held after it.
- No other insider bought within 30 days.
Insider activity: CEO jeereddi Prasad Anjaneya bought about $1.8K of EHSI on Apr 29, 2026.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Jan 6, 2026.
- -7.4% median (-7.4% mean) 90-day return after 2 previous buys.
- The trade is 1.4% of the 225,716 shares held after it.
- No other insider bought within 30 days.
Insider activity: CEO jeereddi Prasad Anjaneya bought about $4.6K of EHSI on Jan 8, 2026.7 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net +$52.6K over 180 days
+$40.0K of it by a 10%+ holder
more than 76% of Healthcare Services
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
no revenue reported in any filing
Margin
-762.1% net margin
below 99% of Healthcare Services
Buybacks
no share repurchases reported
Short interest
<0.1% of the float short (float per yahoo 2026-10-27) · 1.0 days to cover · settled 2026-10-15
the lowest in Healthcare Services
What changed in the last 30 days
Oct 28Insider buying stopped: no purchases in 90 days after 3 in the prior 90
Why it matters
The absence is the signal: 3 purchases in one 90-day window and none in the next is a change of behaviour, not a filing.
Watch EHSI
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-41.1%12M
Insider buy
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns EHSI: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in EHSI
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
EHSI planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return · PEO1
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$125.0K
$125.0K
$0
+96%
n/a
2022
$188.0K
$188.0K
$0
+248%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $52.6K bought by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
EHSI financials
Net margin
-762.1%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$3.7M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM EHSI
| FY Dec 2025 | $1.0M |
| FY Dec 2024 | $0 |
| FY Dec 2023 | $0 |
| FY Dec 2022 | $0 |
| FY Dec 2021 | $1.1M |
| Jun 2026 | $1.3M |
| Mar 2026 | $1.4M |
| Dec 2025 | $1.0M |
| Sep 2025 | $0 |
| Jun 2025 | $0 |
| Mar 2025 | $0 |
| Dec 2024 | $0 |
| Sep 2024 | $0 |
At each fiscal year end
Single quarter
Net margin, TTM
-261.7%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM EHSI
| FY Dec 2025 | -762.1% |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | -83.0% |
| Jun 2026 | -116.9% |
| Mar 2026 | -92.6% |
| Dec 2025 | -564.3% |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM EHSI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Debt to equity
1.60x
long-term debt only, 2017-12-31 (103 months older than the period end); equity 2026-06-30
Debt to equity EHSI
| FY Dec 2025 | 0.77x |
| FY Dec 2024 | 0.98x |
| FY Dec 2023 | 6.36x |
| FY Dec 2022 | 3.31x |
| FY Dec 2021 | 1.59x |
| Jun 2026 | 1.60x |
| Mar 2026 | 1.01x |
| Dec 2025 | 0.77x |
| Sep 2025 | 0.82x |
| Jun 2025 | 1.08x |
| Mar 2025 | 0.97x |
| Dec 2024 | 0.98x |
| Sep 2024 | 1.12x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-1.20x
TTM operating cash flow over long-term debt only, 2017-12-31 (103 months older than the period end)
Cash flow to debt EHSI
| FY Dec 2025 | -0.72x |
| FY Dec 2024 | -0.37x |
| FY Dec 2023 | -0.22x |
| FY Dec 2022 | -0.34x |
| FY Dec 2021 | 0.04x |
| Jun 2026 | -1.20x |
| Mar 2026 | -0.95x |
| Dec 2025 | -0.72x |
| Sep 2025 | -0.48x |
| Jun 2025 | -0.30x |
| Mar 2025 | -0.33x |
| Dec 2024 | -0.37x |
| Sep 2024 | -0.32x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-307.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity EHSI
| FY Dec 2025 | -164.5% |
| FY Dec 2024 | -85.2% |
| FY Dec 2023 | -86.5% |
| FY Dec 2022 | -82.3% |
| FY Dec 2021 | -28.1% |
| Jun 2026 | -307.3% |
| Mar 2026 | -209.3% |
| Dec 2025 | -164.5% |
| Sep 2025 | -70.2% |
| Jun 2025 | -75.2% |
| Mar 2025 | -95.0% |
| Dec 2024 | -85.2% |
| Sep 2024 | -55.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-247.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets EHSI
| FY Dec 2025 | -142.1% |
| FY Dec 2024 | -72.8% |
| FY Dec 2023 | -53.1% |
| FY Dec 2022 | -57.7% |
| FY Dec 2021 | -22.4% |
| Jun 2026 | -247.2% |
| Mar 2026 | -177.9% |
| Dec 2025 | -142.1% |
| Sep 2025 | -66.9% |
| Jun 2025 | -62.0% |
| Mar 2025 | -62.6% |
| Dec 2024 | -72.8% |
| Sep 2024 | -50.5% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital EHSI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-181.6%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed EHSI
| FY Dec 2025 | -80.4% |
| FY Dec 2024 | -72.6% |
| FY Dec 2023 | -70.2% |
| FY Dec 2022 | -61.0% |
| FY Dec 2021 | -2.6% |
| Jun 2026 | -181.6% |
| Mar 2026 | -113.0% |
| Dec 2025 | -80.4% |
| Sep 2025 | -57.8% |
| Jun 2025 | -59.7% |
| Mar 2025 | -74.8% |
| Dec 2024 | -72.6% |
| Sep 2024 | -70.3% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing EHSI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$26.5M
market value at close 2026-10-27 on 2026-08-19 shares, plus long-term debt only, 2017-12-31 (103 months older than the period end), minus cash 2026-06-30
Enterprise value EHSI
| FY Dec 2025 | $28.0M |
| FY Dec 2024 | $14.0M |
| FY Dec 2023 | $7.2M |
| FY Dec 2022 | $3.4M |
| FY Dec 2021 | $3.7M |
| Jun 2026 | $31.6M |
| Mar 2026 | $29.1M |
| Dec 2025 | $28.0M |
| Sep 2025 | $26.3M |
| Jun 2025 | $25.6M |
| Mar 2025 | $18.0M |
| Dec 2024 | $14.0M |
| Sep 2024 | $10.7M |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield EHSI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing EHSI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $1.0M | $0 | $0 | $0 |
| Gross profit | $118.0K | $0 | n/a | n/a |
| Operating income | -$3.8M | -$1.8M | -$765.0K | -$1.4M |
| Net income | -$7.8M | -$2.1M | -$816.0K | -$1.6M |
| EPS (diluted) | n/a | n/a | -0.17 | -0.17 |
| Operating cash flow | -$2.9M | -$1.5M | -$891.0K | -$1.4M |
| Cash | $3.8M | $4.0M | $466.0K | $1.5M |
SEC XBRL, fiscal years, as known on 2026-10-28
EHSI Stock Sonar score 4/7 axes
Find similar shapesCompareEHSI ranks highest on risk and compliance (83rd percentile) and insider conviction (69th), and lowest on profitability (6th), among Healthcare Services peers.
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
EHSI filings, in plain words
Are Elite Health Systems insiders buying or selling EHSI?
In the 180 days to 2026-10-28, Elite Health Systems insiders were net buyers, a net $52.6K across purchases and sales reported on Form 4, by 1 buyer.
Read the full summary
In the 180 days to 2026-10-28, Elite Health Systems insiders were net buyers of EHSI, a net $52.6K across purchases and sales reported on Form 4 by 1 buyer. Most of that figure, $40.0K, came from a holder of 10% or more rather than an officer or director. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
